sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


COVID-19 Impact on Neuroprotection Market, Global Research Reports 2020-2021

COVID-19 Impact on Neuroprotection Market, Global Research Reports 2020-2021

Category : Pharmaceuticals and Healthcare QY Research Pages :95
Published Date : 2020-06-26

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Neuroprotection Market with our analysts monitoring the situation across the globe.
This report covers market size and forecasts of Neuroprotection, including the following market information: Global Neuroprotection Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Neuroprotection Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Neuroprotection Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) Global Neuroprotection Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) Key market players Major competitors identified in this market include F. Hoffmann-La Roche, Eli Lilly and Company, Daiichi Sankyo Company, Allergan, Novartis, AstraZeneca, Dr. Reddy's Laboratories, Astrocyte Pharmaceuticals, Teva Pharmaceutical Industries, Biogen, etc. Based on the Region: Asia-Pacific (China, Japan, South Korea, India and ASEAN) North America (US and Canada) Europe (Germany, France, UK and Italy) Rest of World (Latin America, Middle East & Africa) Based on the Type: Free Anti-Inflammatory Agents Radical Trapping Agents (Antioxidants) Apoptosis Inhibitors Glutamate Antagonists (Anti-Excitotoxic Agents) Neurotrophic Factors (NTFs) Stimulants Metal Ion Chelators Other Products Based on the Application: Prevention Treatment
1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Neuroprotection Industry 1.7 COVID-19 Impact: Neuroprotection Market Trends 2 Global Neuroprotection Quarterly Market Size Analysis 2.1 Neuroprotection Business Impact Assessment - COVID-19 2.1.1 Global Neuroprotection Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Neuroprotection Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 By Players, Global Neuroprotection Quarterly Market Size, 2019 VS 2020 3.2 By Players, Neuroprotection Headquarters and Area Served 3.3 Date of Key Players Enter into Neuroprotection Market 3.4 Key Players Neuroprotection Product Offered 3.5 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Neuroprotection Segments, By Type 4.1 Introduction 1.4.1 Free Anti-Inflammatory Agents 1.4.2 Radical Trapping Agents (Antioxidants) 1.4.3 Apoptosis Inhibitors 1.4.4 Glutamate Antagonists (Anti-Excitotoxic Agents) 1.4.5 Neurotrophic Factors (NTFs) 1.4.6 Stimulants 1.4.7 Metal Ion Chelators 1.4.8 Other Products 4.2 By Type, Global Neuroprotection Market Size, 2019-2021 5 Impact of Covid-19 on Neuroprotection Segments, By Application 5.1 Overview 5.5.1 Prevention 5.5.2 Treatment 5.2 By Application, Global Neuroprotection Market Size, 2019-2021 5.2.1 By Application, Global Neuroprotection Market Size by Application, 2019-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 F. Hoffmann-La Roche 7.1.1 F. Hoffmann-La Roche Business Overview 7.1.2 F. Hoffmann-La Roche Neuroprotection Quarterly Revenue, 2020 7.1.3 F. Hoffmann-La Roche Neuroprotection Product Introduction 7.1.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments 7.2 Eli Lilly and Company 7.2.1 Eli Lilly and Company Business Overview 7.2.2 Eli Lilly and Company Neuroprotection Quarterly Revenue, 2020 7.2.3 Eli Lilly and Company Neuroprotection Product Introduction 7.2.4 Eli Lilly and Company Response to COVID-19 and Related Developments 7.3 Daiichi Sankyo Company 7.3.1 Daiichi Sankyo Company Business Overview 7.3.2 Daiichi Sankyo Company Neuroprotection Quarterly Revenue, 2020 7.3.3 Daiichi Sankyo Company Neuroprotection Product Introduction 7.3.4 Daiichi Sankyo Company Response to COVID-19 and Related Developments 7.4 Allergan 7.4.1 Allergan Business Overview 7.4.2 Allergan Neuroprotection Quarterly Revenue, 2020 7.4.3 Allergan Neuroprotection Product Introduction 7.4.4 Allergan Response to COVID-19 and Related Developments 7.5 Novartis 7.5.1 Novartis Business Overview 7.5.2 Novartis Neuroprotection Quarterly Revenue, 2020 7.5.3 Novartis Neuroprotection Product Introduction 7.5.4 Novartis Response to COVID-19 and Related Developments 7.6 AstraZeneca 7.6.1 AstraZeneca Business Overview 7.6.2 AstraZeneca Neuroprotection Quarterly Revenue, 2020 7.6.3 AstraZeneca Neuroprotection Product Introduction 7.6.4 AstraZeneca Response to COVID-19 and Related Developments 7.7 Dr. Reddy's Laboratories 7.7.1 Dr. Reddy's Laboratories Business Overview 7.7.2 Dr. Reddy's Laboratories Neuroprotection Quarterly Revenue, 2020 7.7.3 Dr. Reddy's Laboratories Neuroprotection Product Introduction 7.7.4 Dr. Reddy's Laboratories Response to COVID-19 and Related Developments 7.8 Astrocyte Pharmaceuticals 7.8.1 Astrocyte Pharmaceuticals Business Overview 7.8.2 Astrocyte Pharmaceuticals Neuroprotection Quarterly Revenue, 2020 7.8.3 Astrocyte Pharmaceuticals Neuroprotection Product Introduction 7.8.4 Astrocyte Pharmaceuticals Response to COVID-19 and Related Developments 7.9 Teva Pharmaceutical Industries 7.9.1 Teva Pharmaceutical Industries Business Overview 7.9.2 Teva Pharmaceutical Industries Neuroprotection Quarterly Revenue, 2020 7.9.3 Teva Pharmaceutical Industries Neuroprotection Product Introduction 7.9.4 Teva Pharmaceutical Industries Response to COVID-19 and Related Developments 7.10 Biogen 7.10.1 Biogen Business Overview 7.10.2 Biogen Neuroprotection Quarterly Revenue, 2020 7.10.3 Biogen Neuroprotection Product Introduction 7.10.4 Biogen Response to COVID-19 and Related Developments 8 Key Findings 9 Appendix 9.1 About US 9.2 Disclaimer

Get Free Sample

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Neuroprotection Assessment Table 9. COVID-19 Impact: Neuroprotection Market Trends Table 10. COVID-19 Impact Global Neuroprotection Market Size Table 11. Global Neuroprotection Quarterly Market Size, 2020 (US$ Million) Table 12. Global Neuroprotection Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 13. Global Neuroprotection Market Growth Drivers Table 14. Global Neuroprotection Market Restraints Table 15. Global Neuroprotection Market Opportunities Table 16. Global Neuroprotection Market Challenges Table 17. By Players, Neuroprotection Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 18. Key Players, Neuroprotection Revenue Market Share, 2019 VS 2020 (%) Table 19. Key Neuroprotection Players Headquarters and Area Served Table 20. Date of Key Players Enter into Neuroprotection Market Table 21. Key Players Neuroprotection Product Type Table 22. Mergers & Acquisitions, Expansion Plans Table 23. By Players, Global Neuroprotection Market Size 2019-2021, (US$ Million) Table 24. Global Neuroprotection Market Size by Application: 2019-2021 (US$ Million) Table 25. Global Neuroprotection Market Size by Region, 2019-2021 (US$ Million) Table 26. By Country, North America Neuroprotection Market Size, 2019-2021 (US$ Million) Table 27. By Type, US Neuroprotection Market Size, 2019-2021 (US$ Million) Table 28. By Application, US Neuroprotection Market Size, 2019-2021 (US$ Million) Table 29. By Type, Canada Neuroprotection Market Size, 2019-2021 (US$ Million) Table 30. By Application, Canada Neuroprotection Market Size, 2019-2021 (US$ Million) Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 32. By Country, Europe Neuroprotection Market Size, 2019-2021 (US$ Million) Table 33. By Type, Germany Neuroprotection Market Size, 2019-2021 (US$ Million) Table 34. By Application, Germany Neuroprotection Market Size, 2019-2021 (US$ Million) Table 35. By Type, France Neuroprotection Market Size, 2019-2021 (US$ Million) Table 36. By Application, France Neuroprotection Market Size, 2019-2021 (US$ Million) Table 37. By Type, UK Neuroprotection Market Size, 2019-2021 (US$ Million) Table 38. By Application, UK Neuroprotection Market Size, 2019-2021 (US$ Million) Table 39. By Type, Italy Neuroprotection Market Size, 2019-2021 (US$ Million) Table 40. By Application, Italy Neuroprotection Market Size, 2019-2021 (US$ Million) Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 42. By Region, Asia-Pacific Neuroprotection Market Size, 2019-2021 (US$ Million) Table 43. By Type, China Neuroprotection Market Size, 2019-2021 (US$ Million) Table 44. By Application, China Neuroprotection Market Size, 2019-2021 (US$ Million) Table 45. By Type, Japan Neuroprotection Market Size, 2019-2021 (US$ Million) Table 46. By Application, Japan Neuroprotection Market Size, 2019-2021 (US$ Million) Table 47. By Type, South Korea Neuroprotection Market Size, 2019-2021 (US$ Million) Table 48. By Application, South Korea Neuroprotection Market Size, 2019-2021 (US$ Million) Table 49. By Type, India Neuroprotection Market Size, 2019-2021 (US$ Million) Table 50. By Application, India Neuroprotection Market Size, 2019-2021 (US$ Million) Table 51. By Type, ASEAN Neuroprotection Market Size, 2019-2021 (US$ Million) Table 52. By Application, ASEAN Neuroprotection Market Size, 2019-2021 (US$ Million) Table 53. By Type, Latin America Neuroprotection Market Size, 2019-2021 (US$ Million) Table 54. By Application, Latin America Neuroprotection Market Size, 2019-2021 (US$ Million) Table 55. By Type, Middle East and Africa Neuroprotection Market Size, 2019-2021 (US$ Million) Table 56. By Application, Middle East and Africa Neuroprotection Market Size, 2019-2021 (US$ Million) Table 57. F. Hoffmann-La Roche Business Overview Table 58. F. Hoffmann-La Roche Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. F. Hoffmann-La Roche Neuroprotection Product Table 60. F. Hoffmann-La Roche Response to COVID-19 and Related Developments Table 61. Eli Lilly and Company Business Overview Table 62. Eli Lilly and Company Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Eli Lilly and Company Neuroprotection Product Table 64. Eli Lilly and Company Response to COVID-19 and Related Developments Table 65. Daiichi Sankyo Company Business Overview Table 66. Daiichi Sankyo Company Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Daiichi Sankyo Company Neuroprotection Product Table 68. Daiichi Sankyo Company Response to COVID-19 and Related Developments Table 69. Allergan Business Overview Table 70. Allergan Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Allergan Neuroprotection Product Table 72. Allergan Response to COVID-19 and Related Developments Table 73. Novartis Business Overview Table 74. Novartis Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Novartis Neuroprotection Product Table 76. Novartis Response to COVID-19 and Related Developments Table 77. AstraZeneca Business Overview Table 78. AstraZeneca Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. AstraZeneca Neuroprotection Product Table 80. AstraZeneca Response to COVID-19 and Related Developments Table 81. Dr. Reddy's Laboratories Business Overview Table 82. Dr. Reddy's Laboratories Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Dr. Reddy's Laboratories Neuroprotection Product Table 84. Dr. Reddy's Laboratories Response to COVID-19 and Related Developments Table 85. Astrocyte Pharmaceuticals Business Overview Table 86. Astrocyte Pharmaceuticals Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. Astrocyte Pharmaceuticals Neuroprotection Product Table 88. Astrocyte Pharmaceuticals Response to COVID-19 and Related Developments Table 89. Teva Pharmaceutical Industries Business Overview Table 90. Teva Pharmaceutical Industries Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. Teva Pharmaceutical Industries Neuroprotection Product Table 92. Teva Pharmaceutical Industries Response to COVID-19 and Related Developments Table 93. Biogen Business Overview Table 94. Biogen Neuroprotection Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Biogen Neuroprotection Product Table 96. Biogen Response to COVID-19 and Related Developments List of Figures Figure 1. Neuroprotection Product Picture Figure 2. Neuroprotection Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Neuroprotection Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Neuroprotection Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Neuroprotection Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Neuroprotection Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Neuroprotection Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Neuroprotection Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Neuroprotection Market Size Market Share, 2019-2021

Get Free Sample

Related Reports

COVID-19 Impact on Neuroprotection Market, Global Research Reports 2020-2021

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

COVID-19 Impact on Neuroprotection Market, Global Research Reports 2020-2021

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

COVID-19 Impact on Neuroprotection Market, Global Research Reports 2020-2021

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

COVID-19 Impact on Neuroprotection Market, Global Research Reports 2020-2021

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

COVID-19 Impact on Neuroprotection Market, Global Research Reports 2020-2021

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)